$MGX 8-K SEC Filings

Filed On	Filing
22 Sep 2026	8-K: Regulation FD Disclosure Precision gene editing designed to deliver durable, curative medicines Corporate Presentation September 2026
10 Aug 2026	8-K: Results of Operations and Financial Condition
10 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
11 May 2026	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
05 Mar 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Regulation FD Disclosure
12 Nov 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
01 Oct 2025	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
12 Aug 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
11 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
14 May 2025	8-K: Other Events
13 May 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
17 Mar 2025	8-K: Entry into a Material Definitive Agreement
17 Mar 2025	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
16 Jan 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
10 Dec 2024	8-K: Other Events
13 Nov 2024	8-K: Results of Operations and Financial Condition
03 Sep 2024	8-K: Other Events
14 Aug 2024	8-K: Results of Operations and Financial Condition
14 May 2024	8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Comments